Identification of the sentinel node in breast cancer patients;Identificatie van de schildwachtklier bij patienten met mammacarcinoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 45, 1996, Pages 2235-2239

  Nieweg, O E ^a   Kapteijn, B A E ^a   Peterse, J L ^a   Rutgers, E J Th ^a   Van Dongen, J A ^a   Kroon, B B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PILOT PROJECTS;

EID: 0029826715     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Boova RS, Bonanni R, Rosato FE. Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection. Ann Surg 1982,196:642-4.
2. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or 'skip' metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 1983;197:276-83.
3. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985;72:368-9.
4. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985,312:674-81.
5. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
6. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983,52:1551-7.
7. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63 181-7.
8. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer An analysis of 259 consecutive patients. Arch Surg 1990;125:1144-7.
9. Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM. A rational approach to the surgical management of melanoma. Ann Surg 1977;186:481-90.
10. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993,11.1536-44.
11. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-6.
12. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986,73:580-4.
13. Tejler G, Aspegren K. Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg 1985;72:542-4
14. Danforth jr DN, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo T, et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 1986;4:655-62
15. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 1986;73:906-8.
16. Musumeci R, Tesoro-Tess JD, Costa A, Veronesi U. Indirect lymphography of the breast with totasul: a vanishing hope? Lymphology 1984;17:118-23.
17. Isaacs RJ, Ford JM, Allan SG, Forgeson GV, Gallagher S. Role of computed tomography in the staging of primary breast cancer. Br J Surg 1993;80:1137.
18. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-70.
19. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993,71:3920-5.
20. Perre CI, Hooge P de, Leguit P. Weinig extra informatie door echografisch onderzoek van de okselklieren bij patienten met een mammacarcinoom Ned Tijdschr Geneeskd 1991;135:1275-7.
21. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative detection with US Radiology 1986,158:325-6.
22. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al Technical details of intraoperative lymphatic mapping for early staae melanoma Arch Surg 1992;127:392-9.
23. Thompson JF, McCarthy WH, Bosch CMJ, O'Brien CJ, Quinn MJ, Paramaesvaran S, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5.255-60.
24. Kapteijn BAE, Baidjnath Panday RKL, Kroon BBR, Liem IH, Rutgers EJT, Muller SH, et al. Identificatie van de eerste-echelonlymfklier bij patiënten met een huidmelanoom. Ned Tijdschr Heelkd 1995;4:159-63.
25. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
26. Meijer S, Pijpers HJ, Veen H van der, Paul MA, Hattum AH van, Hoekstra OS. Schildwachtklieronderzoek om melanoompatiënten te selecteren voor regionale lymfklierdissectie. Ned Tijdschr Geneeskd 1994;138:2491-5
27. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
28. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
29. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
30. Pijpers R, Hoekstra OS, Collet GJ, Meijer S, Teule GJJ Sentinel node biopsie bij het mammacarcinoom. Tijdschr Nucl Geneeskd 1995;17:156-7.
31. Schneebaum S, Stadler J, Baron J, Skornick Y. Gamma probe-guided sentinel node biopsy-optimal timing for injection. Eur J Cancer 1995;31A Suppl 5:S142.
32. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-80.